S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)
Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 66267-158
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 66267-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
66267 158 20
The given text seems to be a medical description including the name, strength, and composition of a medication, Orphenadrine Citrate 100mg. It also includes the product number, lot number, expiration date, serial number, and storage instructions. The text mentions that the medication is an extended-release tablet that could have side effects and warns to keep it away from children. It also provides a contact number to report side effects to the FDA and instructs to call for medical advice about side effects.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
